Domino Liver Transplantation for Unresectable Colon Cancer Liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report

Transplant Proc. 2023 Oct;55(8):1930-1933. doi: 10.1016/j.transproceed.2023.07.012. Epub 2023 Sep 1.

Abstract

Liver transplantation (LT) is a potential curative treatment for unresectable colorectal cancer liver metastasis (CRLM). Familial hypercholesterolemia (FH) is an inherited condition characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels. Liver transplantation is offered for selected cases, and an explanted liver can be used as a domino graft. We report the first report of domino LT for unresectable CRLM using a liver from a patient with heterozygous FH. The domino donor was a 30-year-old female with a history of heterozygous FH. She had failed medical therapies for FH, including plasmapheresis; therefore, she underwent living donor LT as a treatment for FH. The explanted liver was transplanted to the domino recipient. She has been doing well with normal LDL-C levels. The domino recipient was a 44-year-old female with a history of stage 4 sigmoid cancer with liver metastases, for which she underwent laparoscopic sigmoid colectomy and right hepatectomy. She developed unresectable lesions in the remnant left lobe, which were controlled well with chemotherapy; therefore, she underwent domino LT. She is doing well without recurrence at the 31-month follow-up. Domino LT from a donor with heterozygous FH is feasible for strictly selected patients with unresectable CRLM.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cholesterol, LDL
  • Colonic Neoplasms* / genetics
  • Colonic Neoplasms* / surgery
  • Colorectal Neoplasms* / pathology
  • Female
  • Humans
  • Hyperlipidemias*
  • Hyperlipoproteinemia Type II* / complications
  • Hyperlipoproteinemia Type II* / genetics
  • Hyperlipoproteinemia Type II* / surgery
  • Liver Neoplasms* / secondary
  • Liver Neoplasms* / surgery
  • Liver Transplantation* / adverse effects
  • Living Donors

Substances

  • Cholesterol, LDL